China’s People’s Daily newspaper said it was “imperative and urgent” to regulate advertisements bombarding people with recommendations for cosmetic surgery, procedures and treatments, as the ads have become excessive, with some making false claims.
“From posters at bus stops and in subways, to introductions on social Web sites and content platforms, from advertisements planted in films and television variety shows, to promotions by live-streamers, medical beauty advertisements are overwhelmingly pervasive,” the Chinese Communist Party’s official newspaper said in a commentary published on its Web site.
The People’s Daily said that some advertisements associate good looks with “high-quality,” “diligence” and “success,” fabricating stories about “plastic surgery changing one’s destiny” and distorting aesthetic perceptions.
Last month, the Chinese State Administration for Market Regulation drafted guidelines to regulate the medical aesthetics sector’s advertising practices, saying that they were prompting societal anxiety over people’s looks.
Demand for plastic surgery or medical aesthetic treatment has boomed in China in the past few years, with procedures to make one’s eyes wider or nose higher among the most popular.
However, the ads have been criticized for failing to caution people about risks.
In July, a 33-year-old online influencer died from complications after a botched liposuction procedure in a case that was widely reported by media in China.
The market for plastic surgery in China is expected to grow to 300 billion yuan (US$46.54 billion) by next year, the Xinhua news agency reported last month, citing a report by the Chinese Association of Plastics and Aesthetics.
The domestic unit of the Chinese-owned, Dutch-headquartered chipmaker Nexperia BV will soon be able to produce semiconductors locally within China, according to two company sources. Nexperia is at the center of a global tug-of-war over critical semiconductor technology, with a Dutch court in February ordering a probe into alleged mismanagement at the company. The geopolitical tussle has disrupted supply chains, with some carmakers reportedly forced to cut production due to chip shortages. Local production would allow Nexperia’s domestic arm, Nexperia Semiconductors (China) Ltd (安世半導體中國), to bypass restrictions in place since October on the supply of silicon wafers — etched with tiny components to
Singapore-based ride-hailing and delivery giant Grab Holdings Ltd has applied for regulatory approval to acquire the Taiwan operations of Germany-based Delivery Hero SE's Foodpanda in a deal valued at about US$600 million. Grab submitted the filing to the Fair Trade Commission on Friday last week, with the transaction subject to regulatory review and approval, the company said in a statement yesterday. Its independent governance structure would help foster a healthy and competitive market in Taiwan if the deal is approved, Grab said. Grab, which is listed on the NASDAQ, said in the filing that US-based Uber Technologies Inc holds about 13 percent of
Taiwan is open to joining a global liquefied natural gas (LNG) program if one is created, but on the condition that countries provide delivery even in a scenario where there is a conflict with China, an energy department official said yesterday. While Taiwan’s priority is to have enough LNG at home, the nation is open to exploring potential strategic reserves in other countries such as Japan or South Korea, Energy Administration Deputy Director-General Chen Chung-hsien (陳崇憲) said. While the LNG market does not have a global reserve for emergencies like that of oil, the concept has been raised a few times —
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday received government approval to deploy its advanced 3-nanometer (3nm) process at its second fab currently under construction in Japan, the Ministry of Economic Affairs said in a news release. The ministry green-lit the plan for the facility in Kumamoto, which is scheduled to start installing equipment and come online in 2028 with a monthly production capacity of 15,000 12-inch wafers, the ministry said. The Department of Investment Review in June 2024 authorized a US$5.26 billion investment for the facility, slated to manufacture 6- to 12nm chips, significantly less advanced than 3nm process. At a meeting with
RSS